(Q44117645)

30 November 2017

title

Nanobead-based interventions for the treatment and prevention of tuberculosis (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

2

Bo Nyström

1 reference

30 November 2017

3

Suraj B. Sable

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

31 July 2024

author name string

Gareth Griffiths

series ordinal

1

1 reference

30 November 2017

Gopal K. Khuller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

31 July 2024

language of work or name

English

0 references

publication date

12 October 2010

1 reference

full work available at URL

30 November 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

https://europepmc.org/articles/PMC8826847

31 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

https://europepmc.org/articles/PMC8826847?pdf=render

31 July 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

https://doi.org/10.1038/nrmicro2437

31 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20938454

https://www.nature.com/articles/nrmicro2437.pdf

31 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NRMICRO2437

https://www.nature.com/articles/nrmicro2437

31 July 2024

1 reference

https://api.crossref.org/works/10.1038/NRMICRO2437

Nature Reviews Microbiology

31 July 2024

published in

1 reference

30 November 2017

volume

8

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

827-834

1 reference

Selective delivery of rifampicin incorporated into poly(DL-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette-Guérin.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Confronting the scientific obstacles to global control of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

The population dynamics and control of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Tuberculosis: what we don't know can, and does, hurt us.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Multidrug-resistant and extensively drug-resistant tuberculosis: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Host innate immune response to Mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Cell biology of mycobacterium tuberculosis phagosome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Cell-mediated immune responses in tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanotechnology: intelligent design to treat complex disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanoparticles in medicine: therapeutic applications and developments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanoparticle therapeutics: an emerging treatment modality for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Liposome technology for drug delivery against mycobacterial infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Phagocytosis: latex leads the way.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Scavenger receptors: role in innate immunity and microbial pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

The behavior of PLGA microspheres containing rifampicin in alveolar macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Polymer based drug delivery systems for mycobacterial infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Inhalable microparticles containing large payload of anti-tuberculosis drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanoparticle-based targeted drug delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

The potential of azole antifungals against latent/persistent tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanoparticle-based oral drug delivery system for an injectable antibiotic - streptomycin. Evaluation in a murine tuberculosis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Alginate-based sustained release drug delivery systems for tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Advances in tuberculosis vaccine strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Vaccine strategies against latent tuberculosis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Pathogen recognition and development of particulate vaccines: does size matter?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

PLGA microspheres for the delivery of a novel subunit TB vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Inhaled drug delivery for tuberculosis therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Bacteria-mediated delivery of nanoparticles and cargo into cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Immunization by a bacterial aerosol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB/c mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Drying a tuberculosis vaccine without freezing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Nanoparticles for drug delivery to the lungs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Designer adenoviruses for nanomedicine and nanodiagnostics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Fitness of antibiotic-resistant microorganisms and compensatory mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Phenothiazines as anti-multi-drug resistant tubercular agents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Designing dendrimers for biological applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2437

Biodegradation and biocompatibility of PLA and PLGA microspheres

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20938454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20938454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mechanisms of drug resistance in Mycobacterium tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20938454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRMICRO2437

1 reference

National Center for Biotechnology Information

30 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20938454

31 July 2024

1 reference